Uri Weinberg

Insider Reports History

Location
Malvern, PA
Signature
Steven Robbins, as attorney in fact for Weinberg, Uri
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Uri Weinberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Innovation Officer Ordinary Shares 221,218 $4,023,955 $18.19 04 Mar 2025 Direct
NovoCure Ltd Chief Innovation Officer Stock Options (Right to buy) 81,499 $1,482,467 $18.19 04 Mar 2025 Direct

Insider Reports Filed by Uri Weinberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCR NovoCure Ltd 04 Mar 2025 2 +$2,482,462 4 Chief Innovation Officer 06 Mar 2025, 16:41
NVCR NovoCure Ltd 03 Mar 2025 1 -$5,071 4 Chief Innovation Officer 04 Mar 2025, 16:19
NVCR NovoCure Ltd 03 Mar 2025 2 -$86,949 4/A Chief Innovation Officer 03 Mar 2025, 21:27
NVCR NovoCure Ltd 28 Feb 2025 2 -$86,949 4 Chief Innovation Officer 03 Mar 2025, 16:28
NVCR NovoCure Ltd 27 Feb 2024 2 +$3,372,095 4 Chief Innovation Officer 29 Feb 2024, 16:35
NVCR NovoCure Ltd 30 Jun 2023 1 +$10,760 4 Chief Innovation Officer 06 Jul 2023, 16:15
NVCR NovoCure Ltd 03 Mar 2023 2 $0 4 Chief Innovation Officer 06 Mar 2023, 15:43
NVCR NovoCure Ltd 28 Feb 2023 2 +$1,663,091 4 Chief Innovation Officer 02 Mar 2023, 15:58
NVCR NovoCure Ltd 05 Jan 2023 6 -$854,216 4 Chief Science Officer 09 Jan 2023, 17:24
NVCR NovoCure Ltd 05 Jul 2022 1 +$16,600 4 Chief Science Officer 07 Jul 2022, 17:51
NVCR NovoCure Ltd 03 Mar 2022 3 +$2,851,516 4 Chief Science Officer 07 Mar 2022, 17:25
NVCR NovoCure Ltd 06 Jan 2022 1 +$2,234 4 Chief Science Officer 12 Jan 2022, 16:41
NVCR NovoCure Ltd 06 Jul 2021 1 +$15,495 4 Chief Science Officer 08 Jul 2021, 17:38
NVCR NovoCure Ltd 10 May 2021 4 -$888,607 4 Chief Science Officer 12 May 2021, 16:13